“Low dose Galcanezumab for treating trigeminal autonomic cephalalgias: clinical observation from Colombia and Mexico on behalf of ASOLAC”, Headache Med, vol. 16, no. 1, pp. 65–70, Mar. 2025, doi: 10.48208/HeadacheMed.2025.9.